Clinical presentation of pertussis in fully immunized children in Lithuania

Irena Narkeviciute1, Ema Kavaliunaite, Genovaite Bernatoniene

  • 1Center of Pediatrics, Clinic of Children's Diseases, Vilnius University, Santariskiu 4, 08406 Vilnius, Lithuania. irena.narkeviciute@rvuvl.vu.lt

Insights

Despite high pertussis vaccination coverage in Lithuania, fully immunized children are increasingly diagnosed with the disease. This study found that pertussis in vaccinated children typically presents as prolonged, paroxysmal cough, often occurring years after vaccination.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Pertussis (whooping cough) incidence is rising in Lithuania, even among fully vaccinated children.
  • High pertussis vaccination coverage exists, yet breakthrough infections are observed.

Purpose of the Study:

  • To determine the frequency of classical pertussis symptoms in fully vaccinated children.
  • To describe the epidemiology of pertussis in this population.

Main Methods:

  • Investigated 70 children (1 month-15 years) with prolonged cough from May to December 2001.
  • Collected data on demographics, vaccination history, clinical symptoms, and pre-hospitalization treatment.
  • Performed laboratory tests (Bordetella pertussis IgM and IgA) on blood samples.

Main Results:

  • 53 of 70 children (75.7%) had laboratory-confirmed pertussis; 32 were fully vaccinated (whole-cell DTP).
  • Fully vaccinated pertussis cases occurred at a median age of 11 years, 9 years post-vaccination.
  • Classical symptoms like paroxysmal cough (84.4%) were common; atypical symptoms were rare (15.6%).

Conclusions:

  • Pertussis can occur in fully vaccinated children, typically presenting with prolonged cough.
  • Infection often occurs years after the last vaccine dose, with transmission possible in home, school, or daycare settings.
  • Classical pertussis symptoms, though sometimes less severe, remain indicative in vaccinated individuals.
Abstract

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Vaccinations01:51

Vaccinations

Overview
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...